Nestorov Ivan
Zymogenetics Inc., 1201 Eastlake Avenue East, Seattle, Washington 98102, USA.
Expert Opin Drug Metab Toxicol. 2007 Apr;3(2):235-49. doi: 10.1517/17425255.3.2.235.
This review summarizes the most recent developments in and applications of physiologically based pharmacokinetic (PBPK) modeling methodology originating from both the pharmaceutical and environmental toxicology areas. It focuses on works published in the last 5 years, although older seminal papers have also been referenced. After a brief introduction to the field and several essential definitions, the main body of the text is structured to follow the major steps of a typical PBPK modeling exercise. Various applications of the methodology are briefly described. The major future trends and perspectives are outlined. The main conclusion from the review of the available literature is that PBPK modeling, despite its obvious potential and recent incremental developments, has not taken the place it deserves, especially in pharmaceutical and drug development sciences.
本综述总结了源自制药和环境毒理学领域的基于生理的药代动力学(PBPK)建模方法的最新进展及其应用。它重点关注过去5年发表的研究成果,不过也引用了一些较早的经典论文。在对该领域进行简要介绍并给出几个基本定义之后,正文主体部分按照典型PBPK建模实践的主要步骤来组织。文中简要描述了该方法的各种应用。概述了主要的未来趋势和前景。对现有文献进行综述后得出的主要结论是,尽管PBPK建模具有明显潜力且近期有不断发展,但它尚未获得应有的地位,尤其是在制药和药物开发科学领域。